drugset / Trial / NCT00916578
Xeloda (Capecitabine) and External Beam Radiation
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find out if Xeloda® (capecitabine) and radiation therapy can help to control breast cancer that did not respond well to chemotherapy. The safety of this study treatment will also be studied.
Timeline
- Start
- 2009-06-05
- Primary completion
- 2017-06-06
- Completion
- 2017-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 825 mg/m2 | Oral |